J&J Manufacturing Woes Lead To Recall Of Children's Tylenol In Korea
This article was originally published in PharmAsia News
Executive Summary
Johnson & Johnson's Janssen subsidiary ordered a recall of all 1.7 million bottles of its Children's Tylenol syrup produced and sold in South Korea, citing excessive levels of acetaminophen, which could cause liver damage.